We are live on
!
Find out more
PCH
Polar Capital Holdings Portfolio holdings
AUM
$28.2B
1-Year Est. Return
115.26%
This Fund
S&P 500
This Quarter
Est. Return
+12.57%
1 Year Est. Return
+115.26%
3 Year Est. Return
+356.87%
5 Year Est. Return
+474.2%
10 Year Est. Return
–
AUM
$23M
AUM Growth
-$16.1B
(-100%)
Cap. Flow
+$565M
Cap. Flow
% of AUM
2,455.36%
Top 10 Holdings %
Top 10 Hldgs %
41.7%
Holding
389
New
66
Increased
150
Reduced
80
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$194M |
| 2 |
Advanced Micro Devices
AMD
|
+$148M |
| 3 |
Seagate
STX
|
+$130M |
| 4 |
Meta Platforms (Facebook)
META
|
+$124M |
| 5 |
CrowdStrike
CRWD
|
+$99.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$178M |
| 2 |
Alibaba
BABA
|
+$163M |
| 3 |
Analog Devices
ADI
|
+$161M |
| 4 |
Uber
UBER
|
+$133M |
| 5 |
Cadence Design Systems
CDNS
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.28% |
| 2 | Industrials | 21.32% |
| 3 | Healthcare | 15% |
| 4 | Communication Services | 12.09% |
| 5 | Financials | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
276
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.39K | 0.01% |
+58,444
| New | +$2.16M |
|
277
Qiagen
QGEN
$8.72B
| $2.38K | 0.01% |
43,873
-59,863
| -58% | -$3.09M |
|
278
General Dynamics
GD
$106B
| $2.2K | 0.01% |
11,700
| – | – |
|
279
Castle Biosciences
CSTL
$979M
| $2.11K | 0.01% |
+28,761
| New | +$1.9M |
|
|
ARNA
280
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.99K | 0.01% |
29,192
+21,967
| +304% | +$1.43M |
|
281
Tandem Diabetes Care
TNDM
$1.56B
| $1.82K | 0.01% |
18,694
+2,450
| +15% | +$218K |
|
|
IGMS
282
DELISTED
IGM Biosciences
IGMS
| $1.76K | 0.01% |
+21,144
| New | +$1.57M |
|
|
OSH
283
DELISTED
Oak Street Health, Inc.
OSH
| $1.7K | 0.01% |
+28,936
| New | +$1.72M |
|
284
Tenet Healthcare
THC
$21.1B
| $1.67K | 0.01% |
24,870
+12,500
| +101% | +$775K |
|
285
CONMED
CNMD
$1.47B
| $1.55K | 0.01% |
11,314
+5,058
| +81% | +$692K |
|
286
Euronet Worldwide
EEFT
$2.7B
| $1.42K | 0.01% |
10,500
| – | – |
|
287
Golub Capital BDC
GBDC
$3.42B
| $1.35K | 0.01% |
87,850
-3,650
| -4% | -$56.6K |
|
|
CERE
288
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $1.28K | 0.01% |
+50,000
| New | +$716K |
|
289
QuidelOrtho
QDEL
$838M
| $1.22K | 0.01% |
9,525
+1,842
| +24% | +$217K |
|
|
AMRS
290
DELISTED
Amyris Inc.
AMRS
| $1.2K | 0.01% |
73,202
| – | – |
|
|
ACH
291
Accendra Health
ACH
$214M
| $1.19K | 0.01% |
28,054
+6,000
| +27% | +$233K |
|
292
Inspire Medical Systems
INSP
$1.74B
| $1.06K | ﹤0.01% |
5,511
+3,000
| +119% | +$595K |
|
293
Pacira BioSciences
PCRX
$997M
| $1.05K | ﹤0.01% |
+17,368
| New | +$1.1M |
|
294
uniQure
QURE
$3.22B
| $1.03K | ﹤0.01% |
33,476
+11,445
| +52% | +$383K |
|
|
VIVO
295
DELISTED
Meridian Bioscience Inc
VIVO
| $892 | ﹤0.01% |
40,235
| – | – |
|
296
Illumina
ILMN
$28.4B
| $875 | ﹤0.01% |
+1,902
| New | +$766K |
|
297
Arrowhead Research
ARWR
$12.4B
| $824 | ﹤0.01% |
9,945
-12,073
| -55% | -$899K |
|
|
JOBS
298
DELISTED
51job Inc
JOBS
| $813 | ﹤0.01% |
10,454
-90
| -0.9% | -$6.28K |
|
|
ONEM
299
DELISTED
1Life Healthcare
ONEM
| $751 | ﹤0.01% |
22,707
+5,329
| +31% | +$201K |
|
300
Omnicell
OMCL
$1.68B
| $720 | ﹤0.01% |
+4,752
| New | +$662K |
|
Similar funds
N
TWC
FDCDDQ
NA
Polar Capital Holdings's Q2 2021 Portfolio in Review
As of Q2 2021, Polar Capital Holdings held 389 positions worth $23M, down 100% from $16.2B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Polar Capital Holdings deployed $565M of net new capital in Q2 2021, opening 66 new positions and adding to 150 existing holdings. Its largest new stake was Marvell Technology: 3,975,034 shares worth $232K.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Visa, an estimated $178M trimmed.
- Polar Capital Holdings's largest Q2 2021 buy was Marvell Technology: 3,975,034 shares worth $232K.
- Polar Capital Holdings added most to Advanced Micro Devices in Q2 2021, an estimated $148M increase.
- Polar Capital Holdings's biggest Q2 2021 reduction was Visa, cutting an estimated $178M.
- Polar Capital Holdings fully exited Cadence Design Systems in Q2 2021, selling an estimated $129M.
- Polar Capital Holdings's ten largest holdings make up 42% of its $23M portfolio in Q2 2021.
- Polar Capital Holdings opened 66 new positions and closed 39 in Q2 2021.
- Polar Capital Holdings's portfolio value fell 100% quarter-over-quarter to $23M.
Based on Polar Capital Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.